Related references
Note: Only part of the references are listed.Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014
Marie Villumsen et al.
GUT (2019)
Post hoc analysis of the Exenatide-PD trial-Factors that predict response
Dilan Athauda et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
The role of LRRK2 in cell signalling
Kirsten Harvey et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Non-steroidal anti-inflammatory drugs and risk of Parkinson's disease in the elderly population: a meta-analysis
Tahmina Nasrin Poly et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Genetically engineered animal models of Parkinson's disease: From worm to rodent
Ludivine S. Breger et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
PET imaging of [11C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
Katarina Varnas et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress
Li-Li Xu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Can the gut be the missing piece in uncovering PD pathogenesis?
Guillaume Chapelet et al.
PARKINSONISM & RELATED DISORDERS (2019)
Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo
Elena Kozina et al.
BRAIN (2018)
Interleukin-1 beta, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-alpha levels in CSF and serum in relation to the clinical diversity of Parkinson's disease
M. N. Karpenko et al.
CELLULAR IMMUNOLOGY (2018)
Curcumin Suppresses IL-1β Secretion and Prevents Inflammation through Inhibition of the NLRP3 Inflammasome
Haipeng Yin et al.
JOURNAL OF IMMUNOLOGY (2018)
Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease
Chen Qiao et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+Th1/Th2/T17 and Treg in drug-naive and drugtreated patients
Natasa Kustrimovic et al.
JOURNAL OF NEUROINFLAMMATION (2018)
(-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease
Tingting Zhou et al.
MOLECULAR MEDICINE REPORTS (2018)
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease
Seung Pil Yun et al.
NATURE MEDICINE (2018)
Microglial immune checkpoint mechanisms
Aleksandra Deczkowska et al.
NATURE NEUROSCIENCE (2018)
A Combination of Ontogeny and CNS Environment Establishes Microglial Identity
F. Chris Bennett et al.
NEURON (2018)
IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells
Alexandre Pare et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease
Ken Y. Hui et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson's Disease: A Post Hoc Analysis
Dilan Athauda et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
Inga Peter et al.
JAMA NEUROLOGY (2018)
Neuroinflammation: Microglia and T cells Get Ready to Tango
Sjoerd T. T. Schetters et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tetracycline repurposing in neurodegeneration: focus on Parkinson's disease
Mariza Bortolanza et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease A dose-response meta-analysis
Li Ren et al.
MEDICINE (2018)
Is constipation in Parkinson's disease caused by gut or brain pathology?
Per Borghammer
PARKINSONISM & RELATED DISORDERS (2018)
Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention
Sara A. Ferreira et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
A monocyte gene expression signature in the early clinical course of Parkinson's disease
Johannes C. M. Schlachetzki et al.
SCIENTIFIC REPORTS (2018)
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders
Sara Hall et al.
SCIENTIFIC REPORTS (2018)
Interleukin-4 Contributes to Degeneration of Dopamine Neurons in the Lipopolysaccharide-treated Substantia Nigra in vivo
Eugene Bok et al.
EXPERIMENTAL NEUROBIOLOGY (2018)
Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson's Disease
Irene Garcia-Dominguez et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
The Gut and Parkinson's Disease: Hype or Hope?
Filip Scheperjans et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
Jens B. Schroeder et al.
FRONTIERS IN NEUROLOGY (2018)
Astrocyte-Neuron Networks: A Multilane Highway of Signaling for Homeostatic Brain Function
Sara Mederos et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2018)
Development and maintenance of the brain's immune toolkit: Microglia and non-parenchymal brain macrophages
Jose P. Lopez-Atalaya et al.
DEVELOPMENTAL NEUROBIOLOGY (2018)
Microglia and macrophages in brain homeostasis and disease
Qingyun Li et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The meningeal and choroidal infiltration routes for leukocytes in stroke
Corinne Benakis et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson's disease
Katharine M. von Herrmann et al.
NPJ PARKINSONS DISEASE (2018)
Does Parkinson's disease start in the gut?
Arthur Lionnet et al.
ACTA NEUROPATHOLOGICA (2018)
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition
Tuan Leng Tay et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson's Disease
Chen Qiao et al.
MOLECULAR NEUROBIOLOGY (2017)
Genipin protects D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the necroptosis-mediated inflammasome signaling
Min-Jong Seo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Structural and physiological neurovascular changes in idiopathic Parkinson's disease and its clinical phenotypes
Sarah Al-Bachari et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Induction of Adaptive Immunity Leads to Nigrostriatal Disease Progression in MPTP Mouse Model of Parkinson's Disease
Goutam Chandra et al.
JOURNAL OF IMMUNOLOGY (2017)
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease
Lori N. Eidson et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over- induction of monocyte- attracting CCL2 by astrocytes
Vincent R. Parillaud et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Prying into the Prion Hypothesis for Parkinson's Disease
Patrik Brundin et al.
JOURNAL OF NEUROSCIENCE (2017)
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
Dilan Athauda et al.
LANCET (2017)
A new fate mapping system reveals context-dependent random or clonal expansion of microglia
Tuan Leng Tay et al.
NATURE NEUROSCIENCE (2017)
High-dimensional, single-cell characterization of the brain's immune compartment
Ben Korin et al.
NATURE NEUROSCIENCE (2017)
Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice
Sara Belloli et al.
NEUROBIOLOGY OF AGING (2017)
Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide
Eric E. Beier et al.
NEUROBIOLOGY OF DISEASE (2017)
The NLRP3 Inflammasome is Involved in the Pathogenesis of Parkinson's Disease in Rats
Zhijuan Mao et al.
NEUROCHEMICAL RESEARCH (2017)
The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis
Sen Jiang et al.
NEUROLOGICAL SCIENCES (2017)
AN ALTERED BLOOD-BRAIN BARRIER CONTRIBUTES TO BRAIN IRON ACCUMULATION AND NEUROINFLAMMATION IN THE 6-OHDA RAT MODEL OF PARKINSON'S DISEASE
Sonia Olmedo-Diaz et al.
NEUROSCIENCE (2017)
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat
Giulia Ambrosi et al.
NEUROTOXICITY RESEARCH (2017)
Microglial phenotypes in Parkinson's disease and animal models of the disease
Valerie Joers et al.
PROGRESS IN NEUROBIOLOGY (2017)
Nlrp3 Is Required for Inflammatory Changes and Nigral Cell Loss Resulting From Chronic Intragastric Rotenone Exposure in Mice
Eileen M. Martinez et al.
TOXICOLOGICAL SCIENCES (2017)
Coupled Proliferation and Apoptosis Maintain the Rapid Turnover of Microglia in the Adult Brain
Katharine Askew et al.
CELL REPORTS (2017)
Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
Francesca Siani et al.
FRONTIERS IN NEUROSCIENCE (2017)
Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes
Steven Pierce et al.
PLOS ONE (2017)
Quercetin Inhibits Inflammasome Activation by Interfering with ASC Oligomerization and Prevents Interleukin-1 Mediated Mouse Vasculitis
Talita P. Domiciano et al.
SCIENTIFIC REPORTS (2017)
Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson's disease
Souvarish Sarkar et al.
NPJ PARKINSONS DISEASE (2017)
Brain microglia in psychiatric disorders
Valeria Mondelli et al.
LANCET PSYCHIATRY (2017)
Inflammasome activation and innate immunity in Alzheimer's disease
Michael T. Heneka
BRAIN PATHOLOGY (2017)
Ontogeny and homeostasis of CNS myeloid cells
Marco Prinz et al.
NATURE IMMUNOLOGY (2017)
LRRK2 levels in immune cells are increased in Parkinson'sdisease
D. A. Cook et al.
NPJ PARKINSONS DISEASE (2017)
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?
Madelyn C. Houser et al.
NPJ PARKINSONS DISEASE (2017)
Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases
M. Levite
ACTA PHYSIOLOGICA (2016)
Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease
Goutam Chandra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
How can rAAV--synuclein and the fibril -synuclein models advance our understanding of Parkinson's disease?
Laura A. Volpicelli-Daley et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Neuroinflammation: the devil is in the details
Damon J. DiSabato et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Mitochondrial dysfunction in Parkinson's disease
Anindita Bose et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
Caroline H. Williams-Gray et al.
MOVEMENT DISORDERS (2016)
Cdk5-Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease
Pei Zhang et al.
MOVEMENT DISORDERS (2016)
Origin, fate and dynamics of macrophages at central nervous system interfaces
Tobias Goldmann et al.
NATURE IMMUNOLOGY (2016)
Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease
Thibaud Thiollier et al.
SYNAPSE (2016)
Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease A Systematic Review and Meta-analysis
Xiao-Yan Qin et al.
JAMA NEUROLOGY (2016)
Alpha-Synuclein in Parkinson's Disease: From Pathogenetic Dysfunction to Potential Clinical Application
Lingjia Xu et al.
PARKINSONS DISEASE (2016)
Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
Keren Zhou et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice
Chia-Hung Chien et al.
PLOS ONE (2016)
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease
Young C. Chung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2016)
Inflammasomes: mechanism of assembly, regulation and signalling
Petr Broz et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Partial depletion of the proinflammatory monocyte population is neuroprotective in the myenteric plexus but not in the basal ganglia in a MPTP mouse model of Parkinson's disease
M. Cote et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
Yiqing Yan et al.
CELL (2015)
Initiation and perpetuation of NLRP3 inflammasome activation and assembly
Eric I. Elliott et al.
IMMUNOLOGICAL REVIEWS (2015)
Role of Inflammasomes in Intestinal Inflammation and Crohn's Disease
Anthony Opipari et al.
INFLAMMATORY BOWEL DISEASES (2015)
Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome Activation
Ji-Hee Won et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Striatal blood-brain barrier permeability in Parkinson's disease
Madison T. Gray et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Adaptive Immunity in Neurodegenerative and Neuropsychological Disorders
R. Lee Mosley
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
Erdinc Dursun et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Control of adaptive immunity by the innate immune system
Akiko Iwasaki et al.
NATURE IMMUNOLOGY (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease
Ilse S. Pienaar et al.
NEUROBIOLOGY OF DISEASE (2015)
Increased CSF biomarkers of angiogenesis in Parkinson disease
Shorena Janelidze et al.
NEUROLOGY (2015)
Saxagliptin: A novel antiparkinsonian approach
Noha N. Nassar et al.
NEUROPHARMACOLOGY (2015)
ATTENUATION OF MICROGLIAL RANTES BY NEMO-BINDING DOMAIN PEPTIDE INHIBITS THE INFILTRATION OF CD8+ T CELLS IN THE NIGRA OF HEMIPARKINSONIAN MONKEY
A. Roy et al.
NEUROSCIENCE (2015)
Characterization of gastrointestinal disorders in patients with parkinsonian syndromes
Hyeyoung Park et al.
PARKINSONISM & RELATED DISORDERS (2015)
Neuroprotective potential of ferulic acid in the rotenone model of Parkinson's disease
Shreesh Ojha et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation
Sonia George et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Elisa Gomez Perdiguero et al.
NATURE (2015)
Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson's disease: an observational and case-control study
G. T. Kannarkat et al.
NPJ PARKINSONS DISEASE (2015)
Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease
Heather E. Allen Reish et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Inflammatory dysregulation of blood monocytes in Parkinson's disease patients
Veselin Grozdanov et al.
ACTA NEUROPATHOLOGICA (2014)
Role of CCR2 in inflammatory conditions of the central nervous system
Hannah X. Chu et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Cerebral microbleeds in patients with Parkinson's disease
Jee Hyun Ham et al.
JOURNAL OF NEUROLOGY (2014)
Detection of Microglial Activation in an Acute Model of Neuroinflammation Using PET and Radiotracers 11C-(R)-PK11195 and 18F-GE-180
Alex M. Dickens et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Microglial priming in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2014)
Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease
Augusta Pisanu et al.
NEUROBIOLOGY OF DISEASE (2014)
Correlation between Serum RANTES Levels and the Severity of Parkinson's Disease
Peng Tang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system
Roisin C. Thomas et al.
PEPTIDES (2014)
Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats
Joao P. L. Daher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Astrocytic modulation of blood brain barrier: perspectives on parkinson's disease
Ricardo Cabezas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Cognitive Status Correlates with CXCL10/IP-10 Levels in Parkinson's Disease
Natalia Pessoa Rocha et al.
PARKINSONS DISEASE (2014)
Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients
Karlijn J. Doorn et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Distinguishing ecological from evolutionary approaches to transposable elements
Stefan Linquist et al.
BIOLOGICAL REVIEWS (2013)
Doxycycline restrains glia and confers neuroprotection in a 6-OHDA Parkinson model
Marcio Lazzarini et al.
GLIA (2013)
Exenatide and the treatment of patients with Parkinson's disease
Iciar Aviles-Olmos et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
MHCII Is Required for α-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneratione
Ashley S. Harms et al.
JOURNAL OF NEUROSCIENCE (2013)
Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
Goran Lacan et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2013)
Origin of monocytes and macrophages in a committed progenitor
Jan Hettinger et al.
NATURE IMMUNOLOGY (2013)
The microglial sensome revealed by direct RNA sequencing
Suzanne E. Hickman et al.
NATURE NEUROSCIENCE (2013)
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease
S. Iannaccone et al.
PARKINSONISM & RELATED DISORDERS (2013)
Triggering of Inflammasome by Aggregated α-Synuclein, an Inflammatory Response in Synucleinopathies
Gaia Codolo et al.
PLOS ONE (2013)
Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis
Daniel Ness et al.
PLOS ONE (2013)
Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates
Ravid Shechter et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The Role of Innate and Adaptive Immunity in Parkinson's Disease
George T. Kannarkat et al.
JOURNAL OF PARKINSONS DISEASE (2013)
Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease
Elisa Greggio
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson's disease: A self-perpetuating crosstalk?
Mariapia Vairetti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Neuro-protective effects of bee venom by suppression of neuroinflammatory responses in a mouse model of Parkinson's disease: Role of regulatory T cells
Eun Sook Chung et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Implications of Parkinson's Disease Pathophysiology for the Development of Cell Replacement Strategies and Drug Discovery in Neurodegenerative Diseases
Francisco Pan-Montojo et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2012)
Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein
Melanie B. Watson et al.
EXPERIMENTAL NEUROLOGY (2012)
An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28
David R. Owen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy
Brinda Desai Bradaric et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
CD4+Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson's Disease
Jessica A. Hutter Saunders et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease
Valerio Pisani et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Association between Parkinson's disease and the HLA-DRB1 locus
Ismail Ahmed et al.
MOVEMENT DISORDERS (2012)
LONG-TERM POLARIZATION OF MICROGLIA UPON α-SYNUCLEIN OVEREXPRESSION IN NONHUMAN PRIMATES
P. Barkholt et al.
NEUROSCIENCE (2012)
The path from the choroid plexus to the subventricular zone: go with the flow!
Ana Mendanha Falcao et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2012)
IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease (vol 2, e142, 2011)
C. Barcia et al.
CELL DEATH & DISEASE (2012)
Cerebrospinal Fluid Biomarkers for Parkinson Disease Diagnosis and Progression
Min Shi et al.
ANNALS OF NEUROLOGY (2011)
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
Mansoureh Hakimi et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease
Marie-Therese Armentero et al.
NEUROBIOLOGY OF DISEASE (2011)
MPTP-Induced Neuroinflammation Increases the Expression of Pro-Inflammatory Cytokines and Their Receptors in Mouse Brain
Dario Domenico Lofrumento et al.
NEUROIMMUNOMODULATION (2011)
Use of ibuprofen and risk of Parkinson disease
Xiang Gao et al.
NEUROLOGY (2011)
Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region
Erin M. Hill-Burns et al.
PLOS ONE (2011)
IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease
C. Barcia et al.
CELL DEATH & DISEASE (2011)
Lipopolysaccharide Animal Models for Parkinson's Disease
Mei Liu et al.
PARKINSONS DISEASE (2011)
Regulation of learning and memory by meningeal immunity: a key role for IL-4
Noel C. Derecki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Agnes Gardet et al.
JOURNAL OF IMMUNOLOGY (2010)
Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson's Disease
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2010)
Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS
Marco Prinz et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Taye H. Hamza et al.
NATURE GENETICS (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis
Joshua J. Gagne et al.
NEUROLOGY (2010)
Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
Francisco Pan-Montojo et al.
PLOS ONE (2010)
Microglia Acquire Distinct Activation Profiles Depending on the Degree of α-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease
Vanesa Sanchez-Guajardo et al.
PLOS ONE (2010)
Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice
Noah Saederup et al.
PLOS ONE (2010)
Development of Monocytes, Macrophages, and Dendritic Cells
Frederic Geissmann et al.
SCIENCE (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease
Colm Cunningham et al.
BIOLOGICAL PSYCHIATRY (2009)
Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease
Harald Engler et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Elevated interleukin-1β induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine aggravating dopaminergic neurodegeneration in old male mice
Min-juan Bian et al.
BRAIN RESEARCH (2009)
Induction of lymphotoxin-α by interleukin-12 p40 homodimer, the so-called biologically inactive molecule, but not IL-12 p70
Malabendu Jana et al.
IMMUNOLOGY (2009)
Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease
Vanessa Brochard et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
Sehee Kim et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease
Lilia Marinova-Mutafchieva et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Acute and Chronic 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Administrations Elicit Similar Microglial Activation in the Substantia Nigra of Monkeys
Marianne Vazquez-Claverie et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson's Disease
Nicoletta Schintu et al.
NEUROTOXICITY RESEARCH (2009)
CXCR4 and CXCL12 Expression is Increased in the Nigro-Striatal System of Parkinson's Disease
Mika Shimoji et al.
NEUROTOXICITY RESEARCH (2009)
Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease
Dirk W. Luchtman et al.
PHYSIOLOGY & BEHAVIOR (2009)
Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?
Francesca Cicchetti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
Maria Clara Pott Godoy et al.
BRAIN (2008)
A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results
Karl Kieburtz et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases
Avik Roy et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery
Garima Dutta et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2008)
Multiplex analysis of cytokines in the serum and cerebrospinal fluid of patients with Alzheimer's disease by color-coded bead technology
Chulhee Choi et al.
JOURNAL OF CLINICAL NEUROLOGY (2008)
Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA
A. L. Bartels et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
The effects of MPTP on the activation of microglia/astrocytes and cytokine/chemokine levels in different mice strains
Y. Yasuda et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
James B. Koprich et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
Shaji Theodore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
Tamy C. Frank-Cannon et al.
JOURNAL OF NEUROSCIENCE (2008)
Synuclein activates microglia in a model of Parkinson's disease
Xiaomin Su et al.
NEUROBIOLOGY OF AGING (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
Bogdan Brodacki et al.
NEUROSCIENCE LETTERS (2008)
Nitrated α-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Eric J. Benner et al.
PLOS ONE (2008)
The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK–PD experiments
Paulien G.M. Ravenstijn et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2007)
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Bahareh Ajami et al.
NATURE NEUROSCIENCE (2007)
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2007)
Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Y. Yasuda et al.
BRAIN RESEARCH (2007)
Involvement of interferon-γ in microglial-mediated loss of dopaminergic neurons
Matthew P. Mount et al.
JOURNAL OF NEUROSCIENCE (2007)
Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain
Andisheh Eslamboli et al.
BRAIN (2007)
Peripheral inflammation and neuroprotection: Systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease
Marie-Therese Armentero et al.
NEUROBIOLOGY OF DISEASE (2006)
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease
Melissa K. McCoy et al.
JOURNAL OF NEUROSCIENCE (2006)
Up-regulation of microglial CD11b expression by nitric oxide
Avik Roy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease
Keiichirou Wada et al.
NEUROREPORT (2006)
Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys
J Miklossy et al.
EXPERIMENTAL NEUROLOGY (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs
S Lesage et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
HL Chen et al.
ANNALS OF NEUROLOGY (2005)
Myelin basic protein-primed T cells of female but not male mice induce nitric-oxide synthase and proinflammatory cytokines in microglia - Implications for gender bias in multiple sclerosis
S Dasgupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
6-Hydroxydopamine-induced alterations in blood-brain barrier permeability
PM Carvey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
ATP mediates rapid microglial response to local brain injury in vivo
D Davalos et al.
NATURE NEUROSCIENCE (2005)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
The choroid plexus in the rise, fall and repair of the brain
DF Emerich et al.
BIOESSAYS (2005)
Microglial activation and dopamine terminal loss in early Parkinson's disease
Y Ouchi et al.
ANNALS OF NEUROLOGY (2005)
Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo
R Kortekaas et al.
ANNALS OF NEUROLOGY (2005)
Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian
C Barcia et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Blood-brain barrier transport of cytokines: A mechanism for neuropathology
WA Banks
CURRENT PHARMACEUTICAL DESIGN (2005)
Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains
K Imamura et al.
ACTA NEUROPATHOLOGICA (2003)
Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease
AM Depino et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Role of very-late antigen-4 (VLA-4) in myelin basic protein-primed T cell contact-induced expression of proinflammatory cytokines in microglial cells
S Dasgupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation
TB Sherer et al.
EXPERIMENTAL NEUROLOGY (2003)
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration
PL McGeer et al.
ANNALS OF NEUROLOGY (2003)
Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease
K Sriram et al.
FASEB JOURNAL (2002)
Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging
F Cicchetti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease
DC Wu et al.
JOURNAL OF NEUROSCIENCE (2002)
RANTES: a versatile and controversial chemokine
V Appay et al.
TRENDS IN IMMUNOLOGY (2001)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet et al.
NATURE NEUROSCIENCE (2000)
Share Paper
